Epidemic of COVID-Associated Mucormycosis in India and a road ahead

Abstract

COVID-associated Mucormycosis (CAM) was a peak-hour crisis in India. The situation arose from an unprecedented ICU workload of critical COVID-19 cases, insufficient resources and the impaired immune status of the patient. We recommend strong preventive measures, chemoprophylaxis and Amphotericin-B nebulisation for the effective management of CAM.

Keywords

• COVID-19
• Mucormycosis
• Rhino- orbito cerebral mucormycosis
• Nebulized amphotericin-B